These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 675751)

  • 21. The role of platelets in transient ischemic attacks and cerebral vascular accidents.
    Barnett HJ
    Adv Exp Med Biol; 1978; 102():257-63. PubMed ID: 685753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibitory effect of anisodine on platelet aggregation and adhesion].
    Chen BJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Jun; 20(3):161-3. PubMed ID: 3652851
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiplatelet agents: a review.
    Gantmacher ML
    J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
    Margulies EH; White AM; Sherry S
    Drugs; 1980 Sep; 20(3):179-97. PubMed ID: 7000488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multiparametric index of platelet in vitro aggregation in cerebrovascular disease.
    Gazzaniga PP; Ferroni P; Mina C; Pulcinelli FM; Rizzo PA
    Ital J Neurol Sci; 1987 Dec; 8(6):561-6. PubMed ID: 3429215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 28. Strokes-modern treatment.
    Wright IS
    S Afr Med J; 1968 Oct; 42(40):1063-6. PubMed ID: 4302052
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of platelets in thrombotic and vascular disease.
    Schafer AI; Handin RI
    Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914
    [No Abstract]   [Full Text] [Related]  

  • 30. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.
    Sandercock P; Lindley R; Wardlaw J
    Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating thromboembolic disease.
    Deykin D; Gurewich V; Harker L; Hirsch J
    Geriatrics; 1977 Oct; 32(10):119-21, 125-8. PubMed ID: 302814
    [No Abstract]   [Full Text] [Related]  

  • 33. Does platelet antiaggregant therapy lessen the severity of stroke?
    Grotta JC; Lemak NA; Gary H; Fields WS; Vital D
    Neurology; 1985 May; 35(5):632-6. PubMed ID: 3887210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet-inhibitor drugs' role in coronary artery disease.
    Fuster V; Adams PC; Badimon JJ; Chesebro JH
    Prog Cardiovasc Dis; 1987; 29(5):325-46. PubMed ID: 3547499
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiplatelet treatment in thromboembolic cerebrovascular diseases.
    Candelise L
    Adv Neurol; 1979; 25():287-90. PubMed ID: 506854
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet function inhibitors: their clinical use.
    Fuster V; Didisheim P
    Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
    Eichner ER
    Am J Med; 1984 Sep; 77(3):513-23. PubMed ID: 6383036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.